References
- Bond GR, Woodward RW, Ho M. The growing impact of pediatric pharmaceutical poisoning. J. Pediatr 2012; 160:265–270.e1.
- Vernon DD, Gleich MC. Poisoning and drug overdose. Crit Care Clin 1997; 13:647–667.
- Lacroix J, Gaudreault P, Gauthier M. Admission to a pediatric intensive care unit for poisoning: a review of 105 cases. Crit Care Med 1989; 17:748–750.
- Fazen LE III, Lovejoy FH Jr, Crone RK. Acute poisoning in a children's hospital: a 2-year experience. Pediatrics 1986; 77:144–151.
- Pollack MM, Patel KM, Ruttimann UE. PRISM III: an updated Pediatric Risk of Mortality score. Crit Care Med 1996; 24:743–752.
- U.S. Department of Commerce, United States Census Bureau, 2010 Census Interactive Population Search. Available at: http://www.census.gov/2010census/popmap/ipmtext.php. Accessed August 14, 2013.
- Micromedex® Healthcare Series [Internet database]. Greenwood Village, Colo: Thomson Healthcare. Updated periodically. 2013.
- Finkelstein Y, Hutson JR, Wax PM, Brent J, on behalf of the Toxicology Investigators Consortium (ToxIC) Case Registry. Toxico-surveillance of infant and toddler poisonings in the United States. J Med Toxicol 2012; 8:263–266.
- Bronstein AC, Spyker DA, Cantilena LR Jr, Rumack BH, Dart RC. 2011 Annual report of the American Association of Poison Control Centers’ National Poison Data System (NPDS): 29th Annual Report. Clin Toxicol (Phila) 2012; 50:911–1164.
- Jayashree M, Singhi S. Changing trends and predictors of outcome in patients with acute poisoning admitted to the intensive care. J Trop Pediatr 2011; 57:340–346.
- Kohli U, Kuttiat VS, Lodha R, Kabra SK. Profile of childhood poisoning at a tertiary care centre in North India. Indian J Pediatr 2008; 75:791–794.
- Andiran N, Sarikayalar F. Pattern of acute poisonings in childhood in Ankara: what has changed in twenty years?Turk J Pediatr 2004; 46:147–152.
- Pedapati EV, Bateman ST. Toddlers requiring pediatric intensive care unit admission following at-home exposure to buprenorphine/naloxone. Pediatr Crit Care Med 2011; 12:e102–e107.
- Martin TC, Rocque MA. Accidental and non-accidental ingestion of methadone and buprenorphine in childhood: a single center experience, 1999–2009. Curr Drug Saf2011; 6:12–16.
- Lavonas EJ, Banner W, Bradt P, Bucher-Bartelson B, Brown KR, Rajan P, et al. Root causes, clinical effects, and outcomes of unintentional exposures to buprenorphine by young children. J Pediatr 2013; 163:1377–83.e1–3. doi:10.1016/j.jpeds.2013.06.058. Epub 2013 Aug 29.
- RB Press Release, Reckitt Benckiser Pharmaceuticals Inc. Submits Citizen Petition to US FDA Requesting Action to Mitigate Risk of Pediatric Exposure with Opioid Dependence Treatment; Company Voluntarily Discontinues the Supply of Suboxone® Tablets (buprenorphine and naloxone sublingual tablets [CIII]) in the United States. Available at: http://www.rb.com/site/rkbr/templates/mediainvestorsgeneral2.aspx?pageid = 1332 & cc = gb. Accessed April 9, 2013.
- National Take-Back initiative. Available at: http://www.deadiversion.usdoj.gov/drug_disposal/takeback. Accessed April 28, 2013.
- Kochanek KD, Kirmeyer SE, Martin JA, Strobino DM, Guyer B. Annual summary of vital statistics: 2009. Pediatrics 2012; 129: 338–348.
- Nock MK, Green JG, Hwang I, McLaughlin KA, Sampson NA, Zaslavsky AM, Kessler RC. Prevalence, correlates, and treatment of lifetime suicidal behavior among adolescents: results from the National Comorbidity Survey Replication Adolescent Supplement. JAMA Psychiatry 2013; 70:300–310.